Browsing by Author Ogasawara, S

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 5 of 5
TitleAuthor(s)Issue Date
 
Glycemic control is crucial for the treatment of aldose reductase inhibitor (ARI)
Proceeding/Conference:Lessons from Diabetic AR-deficient Mice
Yamagishi, SIOgasawara, SSugawara, AChung, SSMChung, SKYagihashi, S
2007
 
Health-Related Quality-of-Life Impact of Pembrolizumab Versus Best Supportive Care in Previously Systemically Treated Patients With Advanced Hepatocellular Carcinoma: KEYNOTE-240
Journal:Cancer
Ryoo, BYMerle, PKulkarni, ASCheng, ALBouattour, MLim, HYBreder, VEdeline, JChao, YOgasawara, SYau, TGarrido, MChan, SLDaniele, BNorquist, JMChen, ESiegel, ABZhu, AXFinn, RSKudo, M
2021
 
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: A Subgroup Analysis of Asian Patients in the Phase 3 KEYNOTE-240 Trial
Journal:Liver Cancer
Kudo, MLim, HYCheng, ALChao, YYau, TCCOgasawara, SKurosaki, MMorimoto, NOhkawa, KYamashita, TLee, KHChen, ESiegel, ABRyoo, BY
2020
 
Pembrolizumab as second-line therapy in patients with advanced hepatocellular carcinoma in KEYNOTE-240: a randomized, double-blind, phase III trial
Journal:Journal of Clinical Oncology
Finn, RSRyoo, B-YMerle, PKudo, MBouattour, MLim, HYBreder, VEdeline, JChao, YOgasawara, SYau, TGarrido, MChan, SLKnox, JDaniele, BEbbinghaus, SWChen, ESiegel, ABZhu, AXCheng, A-LThe KEYNOTE-240 investigators
2020
 
The role of the polyol pathway in acute kidney injury caused by hindlimb ischaemia in mice
Journal:Journal of Pathology
Yagihashi, SMizukami, HOgasawara, SYamagishi, SINukada, HKato, NHibi, CChung, SChung, S
2010
Showing results 1 to 5 of 5